This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Altavant Sciences Gmbh, Ohr Pharmaceutical Inc., Other. Active years: 2014-2021.
Company Filing History:
1 out of 8 
1 out of 6 
1 out of 834,411 Years Active: 2014-2021
Title: Roy C Levitt, Jr: Innovator in Lower Airways Therapy
Introduction
Roy C Levitt, Jr. is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of medical therapies, particularly focusing on inflammatory disorders of the lower airways. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Levitt's latest patents include innovative methods for treating inflammatory disorders of the lower airways using proinflammatory cytokine inhibitors. One of his patents describes a method for administering an effective amount of anakinra directly to the lower airways of a human subject. This method aims to provide relief for individuals suffering from such disorders. Another patent outlines a kit that includes a delivery device and a pharmaceutical composition for administering agents that modulate the expression and activity of proinflammatory cytokines, such as IL-1, IL-6, IL-8, and TNF-alpha. The delivery device may include various forms such as nebulizers and inhalers, enhancing the accessibility of treatment.
Career Highlights
Throughout his career, Levitt has worked with various companies, including Altavant Sciences GmbH. His experience in the industry has allowed him to develop and refine his innovative approaches to therapy.
Collaborations
Levitt has collaborated with professionals such as Eric Chellquist and Mary Doubleday, contributing to the advancement of his research and inventions.
Conclusion
Roy C Levitt, Jr. stands out as an inventor dedicated to improving treatments for lower airway inflammatory disorders. His innovative patents and collaborations reflect his commitment to advancing medical therapies.